An exploratory study on the effectiveness of “Calmare therapy” in patients with cancer-related neuropathic pain: A pilot study

Abstract Purpose Calmare therapy (CT) has been suggested as a novel treatment for managing chronic pain. Recently, it was reported to show a positive therapeutic outcome for managing neuropathic pain condition. We performed an exploratory prospective study on the effectiveness of CT in patients with...

Full description

Saved in:
Bibliographic Details
Published in:European journal of oncology nursing : the official journal of European Oncology Nursing Society 2016-04, Vol.21, p.1-7
Main Authors: Lee, Sang Chul, Park, Keun Suk, Moon, Jee Youn, Kim, Eun Jung, Kim, Yong-Chul, Seo, Hyejin, Sung, Joon Kyung, Lee, Da Jeong
Format: Article
Language:English
Subjects:
Adult
Aged
Antineoplastic Agents - adverse effects
Calmare therapy
Cancer pain
Cancer Pain - therapy
Female
Hematology, Oncology and Palliative Medicine
Humans
Male
Middle Aged
Neuralgia - etiology
Neuralgia - therapy
Neuropathic pain
Noninvasive approach
Nursing
Pain management
Pain, Postoperative - etiology
Pain, Postoperative - therapy
Pilot Projects
Prospective Studies
Scrambler therapy
Transcutaneous Electric Nerve Stimulation
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Purpose Calmare therapy (CT) has been suggested as a novel treatment for managing chronic pain. Recently, it was reported to show a positive therapeutic outcome for managing neuropathic pain condition. We performed an exploratory prospective study on the effectiveness of CT in patients with various types of cancer-related neuropathic pain (CNP). Method We performed an open-labeled, single-arm, exploratory study on the effectiveness of CT in patients with various types of cancer-related neuropathic pain (CNP). The primary endpoint was a comparison of the 11-point Numerical Rating Scale (NRS) pain score at one month with the baseline score in each patient. Brief Pain Inventory (BPI) and consumption of opioid were also evaluated during follow-up period. Results CT significantly decreased NRS pain score at one month from baseline (p 
ISSN:1462-3889
1532-2122
DOI:10.1016/j.ejon.2015.12.001